210 related articles for article (PubMed ID: 31593523)
21. Conflicts of Interest in Clinical Guidelines: Update of U.S. Preventive Services Task Force Policies and Procedures.
Ngo-Metzger Q; Moyer V; Grossman D; Ebell M; Woo M; Miller T; Brummer T; Chowdhury J; Kato E; Siu A; Phillips W; Davidson K; Phipps M; Bibbins-Domingo K
Am J Prev Med; 2018 Jan; 54(1S1):S70-S80. PubMed ID: 29254528
[TBL] [Abstract][Full Text] [Related]
22. Implementation of financial disclosure policies to manage conflicts of interest.
Boyd EA; Lipton S; Bero LA
Health Aff (Millwood); 2004; 23(2):206-14. PubMed ID: 15046145
[TBL] [Abstract][Full Text] [Related]
23. Managing ethical performance in organizations: insights from the corporate world.
Soule E
Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S73-6; discussion S77-80. PubMed ID: 17471621
[TBL] [Abstract][Full Text] [Related]
24. Conflict of interest and professional medical associations: the North American Spine Society experience.
Schofferman JA; Eskay-Auerbach ML; Sawyer LS; Herring SA; Arnold PM; Muehlbauer EJ
Spine J; 2013 Aug; 13(8):974-9. PubMed ID: 23092717
[TBL] [Abstract][Full Text] [Related]
25. Conflicts of interest in academic research: policies, processes, and attitudes.
Lipton S; Boyd EA; Bero LA
Account Res; 2004; 11(2):83-102. PubMed ID: 15675050
[TBL] [Abstract][Full Text] [Related]
26. Industry Support of Patient Advocacy Organizations: The Case for an Extension of the Sunshine Act Provisions of the Affordable Care Act.
McCoy MS
Am J Public Health; 2018 Aug; 108(8):1026-1030. PubMed ID: 29927655
[TBL] [Abstract][Full Text] [Related]
27. [Transparency in relations between multinational R&D pharmaceutical companies' corporate social responsibility activities and patient organizations in the Europe, Japan, and the United States].
Kato M; Ishikawa H; Okuhara T; Kiuchi T
Nihon Koshu Eisei Zasshi; 2019; 66(12):746-755. PubMed ID: 31875625
[TBL] [Abstract][Full Text] [Related]
28. Creating an institutional conflict-of-interest policy at Johns Hopkins: progress and lessons learned.
Miller ED
Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S70-2; discussion S77-80. PubMed ID: 17469476
[TBL] [Abstract][Full Text] [Related]
29. Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.
Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kulakowski P; Vardas P;
Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):471-8. PubMed ID: 22464101
[TBL] [Abstract][Full Text] [Related]
30. Conflicts of interest and conflicts of commitment.
Werhane P; Doering J
Prof Ethics; 1995; 4(3-4):47-81. PubMed ID: 11655040
[No Abstract] [Full Text] [Related]
31. Conflict-of-interest policies for investigators in clinical trials.
Lo B; Wolf LE; Berkeley A
N Engl J Med; 2000 Nov; 343(22):1616-20. PubMed ID: 11096170
[TBL] [Abstract][Full Text] [Related]
32. Analysis of conflict of interest policies among organizations producing clinical practice guidelines.
Brems JH; Davis AE; Clayton EW
PLoS One; 2021; 16(4):e0249267. PubMed ID: 33930893
[TBL] [Abstract][Full Text] [Related]
33. Principles and process in the development of the Mayo Clinic's individual and institutional conflict of interest policy.
Camilleri M; Gamble GL; Kopecky SL; Wood MB; Hockema ML
Mayo Clin Proc; 2005 Oct; 80(10):1340-6. PubMed ID: 16212147
[TBL] [Abstract][Full Text] [Related]
34. Conflicts of interest and your physician: psychological processes that cause unexpected changes in behavior.
Sah S
J Law Med Ethics; 2012; 40(3):482-7. PubMed ID: 23061575
[TBL] [Abstract][Full Text] [Related]
35. Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest.
Rothman DJ; McDonald WJ; Berkowitz CD; Chimonas SC; DeAngelis CD; Hale RW; Nissen SE; Osborn JE; Scully JH; Thomson GE; Wofsy D
JAMA; 2009 Apr; 301(13):1367-72. PubMed ID: 19336712
[TBL] [Abstract][Full Text] [Related]
36. The challenge for NIH ethics policies: preserving public trust and biomedical progress.
Bravo NR
Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S29-31; discussion S32-7. PubMed ID: 17469471
[TBL] [Abstract][Full Text] [Related]
37. How do health consumer organisations in Australia manage pharmaceutical industry sponsorship? A cross-sectional study.
Lau E; Fabbri A; Mintzes B
Aust Health Rev; 2019 Aug; 43(4):474-480. PubMed ID: 30021681
[TBL] [Abstract][Full Text] [Related]
38. A comparison of policy provisions for managing "financial" and "non-financial" interests across health-related research organizations: A qualitative content analysis.
Grundy Q; Mazzarello S; Bero L
Account Res; 2020 May; 27(4):212-237. PubMed ID: 32233796
[TBL] [Abstract][Full Text] [Related]
39. Coalition Priorité Cancer and the pharmaceutical industry in Quebec: conflicts of interest in the reimbursement of expensive cancer drugs?
Hughes D; Williams-Jones B
Healthc Policy; 2013 Aug; 9(1):52-64. PubMed ID: 23968674
[TBL] [Abstract][Full Text] [Related]
40. Survey of conflict-of-interest disclosure policies of ophthalmology journals.
Anraku A; Jin YP; Trope GE; Buys YM
Ophthalmology; 2009 Jun; 116(6):1093-6. PubMed ID: 19376583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
